资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医迅达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
#CA2#
33篇内容 | 1561人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=e0b5393680, topicName=CA2, introduction=CA2, content=null, image=null, comments=33, allHits=1561, url=https://h5.medsci.cn/topic?id=3936, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=17418, tagList=[TagDto(tagId=17418, tagName=CA2)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1602865, encodeId=680f1602865c2, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=NEJM:抗BDCA2抗体Litifilimab对系统性红斑狼疮的治疗作用(LILAC研究), objectType=article, longId=738583, objectId=9adbe3858308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9adbe3858308, replyNumber=0, likeNumber=84, createdTime=2022-09-09, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9adbe3858308, moduleTitle=NEJM:抗BDCA2抗体Litifilimab对系统性红斑狼疮的治疗作用(LILAC研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9adbe3858308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602864, encodeId=8dc316028649b, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=NEJM:抗BDCA2抗体Litifilimab 治疗皮肤红斑狼疮有效和安全, objectType=article, longId=734182, objectId=530be341822b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=530be341822b, replyNumber=0, likeNumber=81, createdTime=2022-08-03, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=530be341822b, moduleTitle=NEJM:抗BDCA2抗体Litifilimab 治疗皮肤红斑狼疮有效和安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=530be341822b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602863, encodeId=a6b816028639c, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=SERCA2氧化还原C674的取代通过激活IRE1α/XBP1s通路促进肺血管重塑, objectType=article, longId=728536, objectId=cb03e28536fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb03e28536fc, replyNumber=0, likeNumber=78, createdTime=2022-06-04, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb03e28536fc, moduleTitle=SERCA2氧化还原C674的取代通过激活IRE1α/XBP1s通路促进肺血管重塑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb03e28536fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602862, encodeId=11431602862f9, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=J Invest Dermatol:口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究, objectType=article, longId=300170, objectId=b00e3001e032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b00e3001e032, replyNumber=0, likeNumber=73, createdTime=2022-03-08, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b00e3001e032, moduleTitle=J Invest Dermatol:口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b00e3001e032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602861, encodeId=f8a91602861e5, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=J Immunother Cancer:Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性:来自CA209-538临床研究, objectType=article, longId=220657, objectId=8c3622065e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c3622065e52, replyNumber=0, likeNumber=63, createdTime=2021-11-22, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c3622065e52, moduleTitle=J Immunother Cancer:Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性:来自CA209-538临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c3622065e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602860, encodeId=74f1160286003, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Nat Commun:BRCA1/BRCA2突变携带者的乳腺癌发病风险研究, objectType=article, longId=207488, objectId=3be820e4881c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be820e4881c, replyNumber=0, likeNumber=76, createdTime=2021-02-24, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be820e4881c, moduleTitle=Nat Commun:BRCA1/BRCA2突变携带者的乳腺癌发病风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be820e4881c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602859, encodeId=dee11602859e0, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Br J Cancer:携带BRCA2突变的乳腺癌患者的生存率分析, objectType=article, longId=207348, objectId=628320e3487c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=628320e3487c, replyNumber=0, likeNumber=81, createdTime=2021-02-21, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=628320e3487c, moduleTitle=Br J Cancer:携带BRCA2突变的乳腺癌患者的生存率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=628320e3487c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602858, encodeId=0cb41602858d7, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Nature Neuroscience: 海马CA2区社交新奇编码及其在22q11.2微缺失小鼠模型中的破坏和拯救, objectType=article, longId=204992, objectId=a9b4204992f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9b4204992f5, replyNumber=0, likeNumber=72, createdTime=2020-12-31, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9b4204992f5, moduleTitle=Nature Neuroscience: 海马CA2区社交新奇编码及其在22q11.2微缺失小鼠模型中的破坏和拯救, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9b4204992f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602857, encodeId=9b12160285eec, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Br J Cancer:ER表达状态对BRCA2突变型乳腺癌预后的影响, objectType=article, longId=201035, objectId=75fa201035f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75fa201035f9, replyNumber=0, likeNumber=104, createdTime=2020-09-23, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75fa201035f9, moduleTitle=Br J Cancer:ER表达状态对BRCA2突变型乳腺癌预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75fa201035f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602856, encodeId=af7c160285608, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Eur Urol:BRCA2基因组区域的前列腺癌风险评估 , objectType=article, longId=197246, objectId=6a7819e246ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a7819e246ad, replyNumber=0, likeNumber=111, createdTime=2020-07-10, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a7819e246ad, moduleTitle=Eur Urol:BRCA2基因组区域的前列腺癌风险评估 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a7819e246ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602855, encodeId=d279160285551, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Brit J Surg:BRCA1和/或BRCA2突变携带者大肠癌风险, objectType=article, longId=192509, objectId=e7681925097d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7681925097d, replyNumber=0, likeNumber=77, createdTime=2020-04-20, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7681925097d, moduleTitle=Brit J Surg:BRCA1和/或BRCA2突变携带者大肠癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7681925097d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602854, encodeId=d739160285436, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=英国NICE批准将PARP抑制剂Lynparza,用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者, objectType=article, longId=186454, objectId=6fbf186454dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fbf186454dd, replyNumber=0, likeNumber=75, createdTime=2020-01-19, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fbf186454dd, moduleTitle=英国NICE批准将PARP抑制剂Lynparza,用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fbf186454dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602853, encodeId=6cce160285353, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Biogen宣布BDCA2单抗BIIB059在皮肤性红斑狼疮和系统性红斑狼疮的2期研究阳性结果, objectType=article, longId=184168, objectId=6fdd184168d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fdd184168d5, replyNumber=0, likeNumber=73, createdTime=2019-12-06, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fdd184168d5, moduleTitle=Biogen宣布BDCA2单抗BIIB059在皮肤性红斑狼疮和系统性红斑狼疮的2期研究阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fdd184168d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602852, encodeId=72e8160285229, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Eur Urol:男性BRCA1和BRCA2变异位点携带者前列腺癌风险研究, objectType=article, longId=180269, objectId=8b7c18026916, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b7c18026916, replyNumber=0, likeNumber=74, createdTime=2019-10-01, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b7c18026916, moduleTitle=Eur Urol:男性BRCA1和BRCA2变异位点携带者前列腺癌风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b7c18026916)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602851, encodeId=eb5c1602851bd, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Circulation:心律失常性心肌病发生前的右心室Ca2+稳定失衡和连接蛋白43功能丧失, objectType=article, longId=179954, objectId=58501e99540c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58501e99540c, replyNumber=0, likeNumber=85, createdTime=2019-09-25, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58501e99540c, moduleTitle=Circulation:心律失常性心肌病发生前的右心室Ca2+稳定失衡和连接蛋白43功能丧失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58501e99540c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602850, encodeId=17131602850b0, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=JAMA Oncology: BRCA2或为非霍奇金淋巴瘤关键基因, objectType=article, longId=176438, objectId=091c1e6438af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=091c1e6438af, replyNumber=0, likeNumber=77, createdTime=2019-07-31, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=091c1e6438af, moduleTitle=JAMA Oncology: BRCA2或为非霍奇金淋巴瘤关键基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=091c1e6438af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602849, encodeId=2e66160284970, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Brit J Cancer:高度和体重指数与BRCA1和BRCA2突变携带者卵巢癌风险, objectType=article, longId=169031, objectId=f0df169031d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0df169031d5, replyNumber=0, likeNumber=93, createdTime=2019-06-25, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0df169031d5, moduleTitle=Brit J Cancer:高度和体重指数与BRCA1和BRCA2突变携带者卵巢癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0df169031d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602848, encodeId=0440160284823, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=J Dent Res:电动力流动增强F-, Ca2+, K+和Na+离子向釉质的传递, objectType=article, longId=159499, objectId=b8851594994c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8851594994c, replyNumber=0, likeNumber=0, createdTime=2019-02-06, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8851594994c, moduleTitle=J Dent Res:电动力流动增强F-, Ca2+, K+和Na+离子向釉质的传递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8851594994c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=功能性消化不良、脂肪肝、CA242增高,是怎么回事呢?, objectType=article, longId=159127, objectId=9d6815912e44, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d6815912e44, replyNumber=0, likeNumber=75, createdTime=2019-01-30, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d6815912e44, moduleTitle=功能性消化不良、脂肪肝、CA242增高,是怎么回事呢?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d6815912e44)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602846, encodeId=ce5a1602846fe, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, objectTitle=Prostate Cancer P D:生殖细胞系BRCA2变异频率的增加与前列腺癌转移相关, objectType=article, longId=156538, objectId=cdc81565387c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdc81565387c, replyNumber=0, likeNumber=52, createdTime=2018-12-25, rootId=0, userName=TZF0810, userId=03ab18968787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdc81565387c, moduleTitle=Prostate Cancer P D:生殖细胞系BRCA2变异频率的增加与前列腺癌转移相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdc81565387c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
CA2
2020-05-29
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
NEJM:抗BDCA2抗体Litifilimab对系统性红斑狼疮的治疗作用(LILAC研究)
84
0
2022-09-09
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
NEJM:抗BDCA2抗体Litifilimab 治疗皮肤红斑狼疮有效和安全
81
0
2022-08-03
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
SERCA2氧化还原C674的取代通过激活IRE1α/XBP1s通路促进肺血管重塑
78
0
2022-06-04
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
J Invest Dermatol:口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究
73
0
2022-03-08
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
J Immunother Cancer:Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性:来自CA209-538临床研究
63
0
2021-11-22
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
Nat Commun:BRCA1/BRCA2突变携带者的乳腺癌发病风险研究
76
0
2021-02-24
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
Br J Cancer:携带BRCA2突变的乳腺癌患者的生存率分析
81
0
2021-02-21
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
Nature Neuroscience: 海马CA2区社交新奇编码及其在22q11.2微缺失小鼠模型中的破坏和拯救
72
0
2020-12-31
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
Br J Cancer:ER表达状态对BRCA2突变型乳腺癌预后的影响
104
0
2020-09-23
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
Eur Urol:BRCA2基因组区域的前列腺癌风险评估
111
0
2020-07-10
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
Brit J Surg:BRCA1和/或BRCA2突变携带者大肠癌风险
77
0
2020-04-20
回复
TZF0810
(审核中...)
关注
已关注
前往app查看评论内容
#CA2#
英国NICE批准将PARP抑制剂Lynparza,用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者
75
0
2020-01-19
回复
TZF0810
(审核中...)
关注